137 related articles for article (PubMed ID: 38677172)
21. Altered force generation and cell-to-cell contractile imbalance in hypertrophic cardiomyopathy.
Kraft T; Montag J
Pflugers Arch; 2019 May; 471(5):719-733. PubMed ID: 30740621
[TBL] [Abstract][Full Text] [Related]
22. Transcriptomic Analysis of Cardiomyocyte Extracellular Vesicles in Hypertrophic Cardiomyopathy Reveals Differential snoRNA Cargo.
James V; Nizamudeen ZA; Lea D; Dottorini T; Holmes TL; Johnson BB; Arkill KP; Denning C; Smith JGW
Stem Cells Dev; 2021 Dec; 30(24):1215-1227. PubMed ID: 34806414
[TBL] [Abstract][Full Text] [Related]
23. Hypertrophic cardiomyopathy dysfunction mimicked in human engineered heart tissue and improved by sodium-glucose cotransporter 2 inhibitors.
Wijnker PJM; Dinani R; van der Laan NC; Algül S; Knollmann BC; Verkerk AO; Remme CA; Zuurbier CJ; Kuster DWD; van der Velden J
Cardiovasc Res; 2024 Mar; 120(3):301-317. PubMed ID: 38240646
[TBL] [Abstract][Full Text] [Related]
24. Hypertrophic Cardiomyopathy: Genetic Foundations, Outcomes, Interconnections, and Their Modifiers.
Glavaški M; Velicki L; Vučinić N
Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629714
[TBL] [Abstract][Full Text] [Related]
25. EGFR/IGF1R Signaling Modulates Relaxation in Hypertrophic Cardiomyopathy.
Algül S; Schuldt M; Manders E; Jansen V; Schlossarek S; de Goeij-de Haas R; Henneman AA; Piersma SR; Jimenez CR; Michels M; Carrier L; Helmes M; van der Velden J; Kuster DWD
Circ Res; 2023 Aug; 133(5):387-399. PubMed ID: 37477020
[TBL] [Abstract][Full Text] [Related]
26. Inducible Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Aberrant Extracellular Regulated Kinase 5 and Mitogen-Activated Protein Kinase Kinase 1/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1-Associated Noonan Syndrome.
Jaffré F; Miller CL; Schänzer A; Evans T; Roberts AE; Hahn A; Kontaridis MI
Circulation; 2019 Jul; 140(3):207-224. PubMed ID: 31163979
[TBL] [Abstract][Full Text] [Related]
27. The PTPN11 loss-of-function mutation Q510E-Shp2 causes hypertrophic cardiomyopathy by dysregulating mTOR signaling.
Schramm C; Fine DM; Edwards MA; Reeb AN; Krenz M
Am J Physiol Heart Circ Physiol; 2012 Jan; 302(1):H231-43. PubMed ID: 22058153
[TBL] [Abstract][Full Text] [Related]
28. Ranolazine Prevents Phenotype Development in a Mouse Model of Hypertrophic Cardiomyopathy.
Coppini R; Mazzoni L; Ferrantini C; Gentile F; Pioner JM; Laurino A; Santini L; Bargelli V; Rotellini M; Bartolucci G; Crocini C; Sacconi L; Tesi C; Belardinelli L; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Poggesi C
Circ Heart Fail; 2017 Mar; 10(3):. PubMed ID: 28255011
[TBL] [Abstract][Full Text] [Related]
29. Sphingosine-1-Phosphate Receptor Modulator, FTY720, Improves Diastolic Dysfunction and Partially Reverses Atrial Remodeling in a Tm-E180G Mouse Model Linked to Hypertrophic Cardiomyopathy.
Ryba DM; Warren CM; Karam CN; Davis RT; Chowdhury SAK; Alvarez MG; McCann M; Liew CW; Wieczorek DF; Varga P; Solaro RJ; Wolska BM
Circ Heart Fail; 2019 Nov; 12(11):e005835. PubMed ID: 31684756
[TBL] [Abstract][Full Text] [Related]
30. Enhanced myofilament calcium sensitivity aggravates abnormal calcium handling and diastolic dysfunction in patient-specific induced pluripotent stem cell-derived cardiomyocytes with MYH7 mutation.
Guo G; Wang L; Li X; Fu W; Cao J; Zhang J; Liu Y; Liu M; Wang M; Zhao G; Zhao X; Zhou Y; Niu S; Liu G; Zhang Y; Dong J; Tao H; Zhao X
Cell Calcium; 2024 Jan; 117():102822. PubMed ID: 38101154
[TBL] [Abstract][Full Text] [Related]
31. Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients.
Wu H; Yang H; Rhee JW; Zhang JZ; Lam CK; Sallam K; Chang ACY; Ma N; Lee J; Zhang H; Blau HM; Bers DM; Wu JC
Eur Heart J; 2019 Dec; 40(45):3685-3695. PubMed ID: 31219556
[TBL] [Abstract][Full Text] [Related]
32. Human engineered cardiac tissue model of hypertrophic cardiomyopathy recapitulates key hallmarks of the disease and the effect of chronic mavacamten treatment.
Wang K; Schriver BJ; Aschar-Sobbi R; Yi AY; Feric NT; Graziano MP
Front Bioeng Biotechnol; 2023; 11():1227184. PubMed ID: 37771571
[No Abstract] [Full Text] [Related]
33. MYH7B variants cause hypertrophic cardiomyopathy by activating the CaMK-signaling pathway.
Chen P; Li Z; Nie J; Wang H; Yu B; Wen Z; Sun Y; Shi X; Jin L; Wang DW
Sci China Life Sci; 2020 Sep; 63(9):1347-1362. PubMed ID: 32207065
[TBL] [Abstract][Full Text] [Related]
34. Pediatric Hypertrophic Cardiomyopathy: Exploring the Genotype-Phenotype Association.
Nguyen MB; Mital S; Mertens L; Jeewa A; Friedberg MK; Aguet J; Adler A; Lam CZ; Dragulescu A; Rakowski H; Villemain O
J Am Heart Assoc; 2022 Mar; 11(5):e024220. PubMed ID: 35179047
[TBL] [Abstract][Full Text] [Related]
35. Altered Cardiac Energetics and Mitochondrial Dysfunction in Hypertrophic Cardiomyopathy.
Ranjbarvaziri S; Kooiker KB; Ellenberger M; Fajardo G; Zhao M; Vander Roest AS; Woldeyes RA; Koyano TT; Fong R; Ma N; Tian L; Traber GM; Chan F; Perrino J; Reddy S; Chiu W; Wu JC; Woo JY; Ruppel KM; Spudich JA; Snyder MP; Contrepois K; Bernstein D
Circulation; 2021 Nov; 144(21):1714-1731. PubMed ID: 34672721
[TBL] [Abstract][Full Text] [Related]
36. Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy.
Tsybouleva N; Zhang L; Chen S; Patel R; Lutucuta S; Nemoto S; DeFreitas G; Entman M; Carabello BA; Roberts R; Marian AJ
Circulation; 2004 Mar; 109(10):1284-91. PubMed ID: 14993121
[TBL] [Abstract][Full Text] [Related]
37. Cardiomyocyte Apoptosis Is Associated with Contractile Dysfunction in Stem Cell Model of
Loiben AM; Chien WM; Friedman CE; Chao LS; Weber G; Goldstein A; Sniadecki NJ; Murry CE; Yang KC
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902340
[TBL] [Abstract][Full Text] [Related]
38. Stress activated signalling impaired protein quality control pathways in human hypertrophic cardiomyopathy.
Hassoun R; Budde H; Zhazykbayeva S; Herwig M; Sieme M; Delalat S; Mostafi N; Gömöri K; Tangos M; Jarkas M; Pabel S; Bruckmüller S; Skrygan M; Lódi M; Jaquet K; Sequeira V; Gambichler T; Remedios CD; Kovács Á; Mannherz HG; Mügge A; Sossalla S; Hamdani N
Int J Cardiol; 2021 Dec; 344():160-169. PubMed ID: 34517018
[TBL] [Abstract][Full Text] [Related]
39. An
Adeniran I; Wadee H; Degens H
Biomed Res Int; 2024; 2024():6160554. PubMed ID: 38567164
[TBL] [Abstract][Full Text] [Related]
40. Familial hypertrophic cardiomyopathy: a paradigm of the cardiac hypertrophic response to injury.
Marian AJ; Roberts R
Ann Med; 1998 Aug; 30 Suppl 1():24-32. PubMed ID: 9800880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
